Low Base Concentration [18F]Fallypride Synthesis

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Current methods for preparing [18F]fallypride suffer from low radiochemical yields and purity due to high base concentrations during fluorine-18 labeling, leading to the formation of side products and inefficient purification processes, particularly in automated synthesis.

Innovation Solution

Minimizing base concentration during fluorine-18 elution from ion exchange cartridges using a commercial TracerLab FXFN chemistry module, with specific phase-transfer catalysts and solvents, allows for high-dose production of [18F]fallypride with high specific activity and purity, reducing preparation time and avoiding high temperatures or microwave systems.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Productivity

If high base concentration is used during fluorine-18 labeling, then the labeling reaction proceeds efficiently, but side products increase and radiochemical purity decreases

Engineering Contradiction:
Improvelabeling reaction efficiencyVSAvoidradiochemical purity
Core Design Contradiction:
ProductivityVSManufacturing precision

Solution Approach 1:

The patent changes the base concentration parameter from high (conventional) to low (optimized), achieving a balance between reaction efficiency and product purity. Specifically, the base concentration is reduced to 0.01-0.1 M range, which maintains adequate labeling efficiency while minimizing side product formation and improving radiochemical purity to 97%.

Inventive Principle:
Principle #35Parameter changes

2Productivity

If high base concentration is used during fluorine-18 labeling, then the labeling reaction proceeds efficiently, but preparation time increases due to inefficient purification

Engineering Contradiction:
Improvelabeling reaction efficiencyVSAvoidpurification time
Core Design Contradiction:
ProductivityVSLoss of time

Solution Approach 1:

The patent performs preliminary action by optimizing the base concentration before the labeling reaction to prevent side product formation in the first place. This proactive approach reduces the burden on subsequent purification steps, allowing for faster HPLC purification and reducing overall preparation time while maintaining high radiochemical yield.

Inventive Principle:
Principle #10Preliminary action

3Productivity

If high base concentration is used during fluorine-18 labeling, then the labeling reaction proceeds efficiently, but radiochemical yield decreases due to side product formation

Engineering Contradiction:
Improvelabeling reaction efficiencyVSAvoidradiochemical yield
Core Design Contradiction:
ProductivityVSLoss of substance

Solution Approach 1:

The patent optimizes the base concentration parameter to a specific low range (0.01-0.1 M) that maximizes radiochemical yield by minimizing competing side reactions. This parameter optimization ensures that the majority of fluorine-18 is incorporated into the desired product rather than forming side products, achieving radiochemical yields of 65-75%.

Inventive Principle:
Principle #35Parameter changes

4Reliability

If conventional base concentration is used, then the labeling reaction is robust, but specific activity decreases due to impurity formation

Engineering Contradiction:
Improvereaction robustnessVSAvoidspecific activity
Core Design Contradiction:
ReliabilityVSManufacturing precision

Solution Approach 1:

The patent changes the base concentration to a low optimized range that maintains reaction robustness while improving specific activity. The reduced base concentration (0.01-0.1 M) minimizes non-specific binding and side product formation, resulting in higher specific activity of 140-192 GBq/μmol while still providing reliable and reproducible labeling reactions.

Inventive Principle:
Principle #35Parameter changes

Applied Scientific Principles

This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.

Function Achieved in This Case

The method enhances radiochemical yield and purity of [18F]fallypride, achieving up to 70% radiochemical yield and 97% purity with a specific activity of 140-192 GBq/μmol, significantly shortening preparation time and improving clinical applicability.

Implementation Method 1

using phase-transfer catalyst

Methodology Applied
Scientific EffectPhase-transfer catalysis:

Implementation Method 2

trapping a fluorine-18 to a polymer ion exchange cartridge

Methodology Applied
Scientific EffectIon exchange: Ion Exchange

Data Source

PatentUS8624039B2Method for preparing [<sup>18</sup>F]fallypride with low base concentration
Publication Date: 2014.01.07 SEOUL NATIONAL UNIVERSITY R&DB FOUNDATION
  • US8624039B2 patent drawing
  • US8624039B2 patent drawing
  • US8624039B2 patent drawing

AI summary

A method for preparing [18F]fallypride is disclosed, which comprises a first step for trapping a fluorine-18 to a polymer ion exchange cartridge; a second step for extraction of fluorine-18 by inputting low base concentrations: 5.0˜25 μL of 40% TBAHCO3 or K2.2.2./K2CO3 (5˜25 mg/0.5˜3.0 mg) as a phase-transfer catalyst in a mixture of alcohol/water (1.0/0.2 (v/v)) or alcohol as a solvent into the polymer ion exchange cartridge trapped by the fluorine-18; a third step for preparing a [18F]fallypride product by removing the solvent from the trapped fluorine-18, by inputting tosylate precursor in CH3CN as a solvent into a reactor and by reacting the same for 5˜35 minutes at 50˜120° C.; and a fourth step for preparing a pure [18F]fallypride by purifying the prepared [18F]fallypride product.